Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2023-000932
Request Summary: Information on the review status of the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017, including but not limited to a screen shot from Health Canada’s Drug Submission Tracking System (DSTS) for this ANDS.
Disposition: Disclosed in part
Number of pages: 10